Page 3 - Sofinnova Partners News Today

BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p....

Despite scale and adoption challenges, funding still flowed into material innovation in 2023.

/PRNewswire/ -- Asceneuron SA, a clinical stage biotech company dedicated to targeting the root causes of neurodegenerative diseases with its exemplary...

What's been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

/PRNewswire/ -- Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today...

14 Dec 2023 - Mission gains clearance from US FDA for Phase II trial of MTX652 after it receives official approval of its Investigational New Drug application ...

Experienced team of serial entrepreneurs and investors will partner with leading academic institutions to identify the most innovative ideas and create the biotech champions of tomorrowPARIS--(BUSINESS WIRE)--#VC--Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris,...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Dec 12, 2023--

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today...